company background image
DICOT logo

Dicot Pharma NGM:DICOT Stock Report

Last Price

SEK 0.23

Market Cap

SEK 409.1m

7D

6.5%

1Y

109.1%

Updated

07 Nov, 2024

Data

Company Financials

Dicot Pharma AB Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dicot Pharma
Historical stock prices
Current Share PriceSEK 0.23
52 Week HighSEK 0.58
52 Week LowSEK 0.096
Beta1.47
11 Month Change27.21%
3 Month Change-24.84%
1 Year Change109.09%
33 Year Change-68.10%
5 Year Change-91.22%
Change since IPO-97.33%

Recent News & Updates

Recent updates

We're Keeping An Eye On Dicot's (NGM:DICOT) Cash Burn Rate

Apr 09
We're Keeping An Eye On Dicot's (NGM:DICOT) Cash Burn Rate

We Think Dicot (NGM:DICOT) Needs To Drive Business Growth Carefully

Dec 23
We Think Dicot (NGM:DICOT) Needs To Drive Business Growth Carefully

Shareholder Returns

DICOTSE PharmaceuticalsSE Market
7D6.5%3.2%1.6%
1Y109.1%32.3%21.2%

Return vs Industry: DICOT exceeded the Swedish Pharmaceuticals industry which returned 37.3% over the past year.

Return vs Market: DICOT exceeded the Swedish Market which returned 20.9% over the past year.

Price Volatility

Is DICOT's price volatile compared to industry and market?
DICOT volatility
DICOT Average Weekly Movement14.8%
Pharmaceuticals Industry Average Movement11.0%
Market Average Movement5.4%
10% most volatile stocks in SE Market11.0%
10% least volatile stocks in SE Market3.1%

Stable Share Price: DICOT's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: DICOT's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20153Elin Trampewww.dicotpharma.com

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024.

Dicot Pharma AB Fundamentals Summary

How do Dicot Pharma's earnings and revenue compare to its market cap?
DICOT fundamental statistics
Market capSEK 409.12m
Earnings (TTM)-SEK 52.66m
Revenue (TTM)n/a

0.0x

P/S Ratio

-7.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DICOT income statement (TTM)
RevenueSEK 0
Cost of RevenueSEK 0
Gross ProfitSEK 0
Other ExpensesSEK 52.66m
Earnings-SEK 52.66m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.03
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did DICOT perform over the long term?

See historical performance and comparison